• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服左炔诺孕酮和炔雌醇在 Roux-en-Y 胃旁路手术后妇女中的药代动力学。

Pharmacokinetics of oral levonorgestrel and ethinylestradiol in women after Roux-en-Y gastric bypass surgery.

机构信息

Grupo de Obesidade e Síndrome Metabólica, Hospital das Clínicas HCFMUSP, Universidade de São Paulo, São Paulo, Brazil.

Grupo de Obesidade e Síndrome Metabólica, Hospital das Clínicas HCFMUSP, Universidade de São Paulo, São Paulo, Brazil; Laboratory of Carbohydrates and Raioimmunoassay, ICHC, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

出版信息

Surg Obes Relat Dis. 2021 Apr;17(4):673-681. doi: 10.1016/j.soard.2020.12.007. Epub 2020 Dec 16.

DOI:10.1016/j.soard.2020.12.007
PMID:33547015
Abstract

BACKGROUND

Most patients undergoing Roux-en-Y gastric bypass (RYGB) are women in reproductive age. It is not known if bariatric surgery affects the pharmacokinetics of oral contraceptives.

OBJECTIVES

The primary objective was to evaluate ethinylestradiol (EE) and levonorgestrel (LNG) absorption in women undergoing RYGB, compared with nonoperated controls matched by age and body mass index (BMI). A secondary objective was to assess whether the time since surgery and BMI in the postoperative period influenced the absorption parameters.

SETTING

University hospital, Brazil.

METHODS

This study was designed to compare the maximum plasma concentration (C), the time to the peak plasma level (T), the area under the curve (AUC and AUC) after a single dose of a combined oral contraceptive with 0.03 mg EE and 0.15 mg LNG among 20 women after RYGB and 20 controls. Blood samples were obtained for 8 hours.

RESULTS

The mean LNG AUC and LNG AUC were higher in RYGB group (P = .048 and P = .004, respectively). We found a positive correlation for LNG AUC (P = .045) and AUC (P = .004) and the time since surgery, and we found a negative correlation for LNG C (P = .018), AUC (P = .003), and AUC (P = .001) and BMI.

CONCLUSION

No significant differences were found in oral EE pharmacokinetics. The operated group showed higher mean LNG AUC and AUC but it was not considered clinically significant. The present study suggests that RYGB may not affect EE and LNG absorption.

摘要

背景

大多数接受 Roux-en-Y 胃旁路术(RYGB)的患者是育龄期女性。目前尚不清楚减肥手术是否会影响口服避孕药的药代动力学。

目的

主要目的是评估与年龄和体重指数(BMI)相匹配的非手术对照组相比,RYGB 术后女性的炔雌醇(EE)和左炔诺孕酮(LNG)吸收情况。次要目的是评估手术时间和术后 BMI 是否影响吸收参数。

地点

巴西大学医院。

方法

本研究旨在比较 20 例 RYGB 术后女性和 20 例对照组单次服用含有 0.03mg EE 和 0.15mg LNG 的复方口服避孕药后的最大血浆浓度(C)、达峰时间(T)、曲线下面积(AUC 和 AUC)。采集 8 小时的血样。

结果

RYGB 组 LNG AUC 和 LNG AUC 均较高(P=0.048 和 P=0.004)。我们发现 LNG AUC(P=0.045)和 AUC(P=0.004)与手术时间呈正相关,而 LNG C(P=0.018)、AUC(P=0.003)和 AUC(P=0.001)与 BMI 呈负相关。

结论

口服 EE 的药代动力学无显著差异。手术组 LNG AUC 和 AUC 均值较高,但无临床意义。本研究表明 RYGB 可能不会影响 EE 和 LNG 的吸收。

相似文献

1
Pharmacokinetics of oral levonorgestrel and ethinylestradiol in women after Roux-en-Y gastric bypass surgery.口服左炔诺孕酮和炔雌醇在 Roux-en-Y 胃旁路手术后妇女中的药代动力学。
Surg Obes Relat Dis. 2021 Apr;17(4):673-681. doi: 10.1016/j.soard.2020.12.007. Epub 2020 Dec 16.
2
Pharmacokinetics of Oral Levonorgestrel in Women After Roux-en-Y Gastric Bypass Surgery and in BMI-Matched Controls.经 Roux-en-Y 胃旁路手术后女性与 BMI 匹配对照者中左炔诺孕酮口服药代动力学。
Obes Surg. 2020 Jun;30(6):2217-2224. doi: 10.1007/s11695-020-04447-x.
3
No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel.丙型肝炎病毒抑制剂艾尔巴韦和格拉瑞韦与口服避孕药炔雌醇和左炔诺孕酮之间不存在具有临床意义的药代动力学相互作用。
Eur J Clin Pharmacol. 2017 May;73(5):593-600. doi: 10.1007/s00228-017-2216-4. Epub 2017 Feb 24.
4
Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants.阿替利珠单抗对健康女性参与者中炔雌醇/左炔诺孕酮口服避孕药的药代动力学无临床相关影响。
J Clin Pharmacol. 2020 Sep;60(9):1157-1165. doi: 10.1002/jcph.1610. Epub 2020 Apr 16.
5
Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study.氟班色林对健康绝经前妇女中雌二醇/左炔诺孕酮复方口服避孕药药代动力学的影响:一项随机交叉研究。
Clin Ther. 2018 Jan;40(1):64-73. doi: 10.1016/j.clinthera.2017.08.021. Epub 2017 Dec 2.
6
Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.左炔诺孕酮和炔雌醇在14名女性使用三步联合口服避孕药治疗三个月期间的药代动力学:左炔诺孕酮的血清蛋白结合以及治疗对血清中游离睾酮和总睾酮水平的影响。
Contraception. 1994 Dec;50(6):563-79. doi: 10.1016/0010-7824(94)90014-0.
7
Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.左炔诺孕酮和炔雌醇在9名女性中的药代动力学研究。这些女性在3个月的治疗期内服用低剂量口服避孕药,经过洗脱期后,单次口服相同的避孕制剂。
Contraception. 1992 Nov;46(5):455-69. doi: 10.1016/0010-7824(92)90149-n.
8
Effect of empagliflozin on the steady-state pharmacokinetics of ethinylestradiol and levonorgestrel in healthy female volunteers.恩格列净对健康女性志愿者体内炔雌醇和左炔诺孕酮稳态药代动力学的影响。
Clin Drug Investig. 2013 May;33(5):351-7. doi: 10.1007/s40261-013-0068-y.
9
Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations.两种口服避孕药制剂给药后炔雌醇和左炔诺孕酮的药代动力学
Exp Clin Endocrinol. 1992;99(1):12-7. doi: 10.1055/s-0029-1211124.
10
A phase 1, open-label study to evaluate the drug interaction between islatravir (MK-8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females.一项评估伊拉曲韦(MK-8591)与健康成年女性口服避孕药左炔诺孕酮/炔雌醇药物相互作用的 1 期、开放性研究。
J Int AIDS Soc. 2021 Dec;24(12):e25858. doi: 10.1002/jia2.25858.

引用本文的文献

1
Impact of Bariatric Surgery in the Short and Long Term: A Need for Time-Dependent Dosing of Drugs.减重手术的短期和长期影响:药物需要随时间调整剂量。
Obes Surg. 2023 Oct;33(10):3266-3302. doi: 10.1007/s11695-023-06770-5. Epub 2023 Aug 18.
2
Considerations for clinical evaluation of the effects of bariatric surgery on the pharmacokinetics of orally administered drugs.减肥手术对口服药物药代动力学影响的临床评估考量
Transl Clin Pharmacol. 2022 Sep;30(3):145-154. doi: 10.12793/tcp.2022.30.e15. Epub 2022 Sep 26.
3
Oral drug dosing following bariatric surgery: General concepts and specific dosing advice.
减重手术后的口服药物给药:一般概念和具体给药建议。
Br J Clin Pharmacol. 2021 Dec;87(12):4560-4576. doi: 10.1111/bcp.14913. Epub 2021 Jun 3.